Results 121 to 130 of about 299,280 (207)

Implementation of Novel Lipid Therapies in a Refractory Heterozygous Familial Hypercholesterolemia Patient With Atherosclerotic Disease. [PDF]

JACC Case Rep, 2022
Weintraub SF, Schillow JA, Azari BM, Hirsh BJ.   +3 more
europepmc   +1 more source

Effects of evolocumab on plasma coenzyme Q10 in patients with heterozygous familial hypercholesterolemia. [PDF]

Atheroscler Plus
Tada H, Takeji Y, Takamura M.
europepmc   +1 more source

PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia. [PDF]

J Cell Mol Med
Woźniak-Szczepocka A, Pawlos A, Gorzelak-Pabiś P, Broncel M, Bukowska B, Woźniak E.   +5 more
europepmc   +1 more source

Whole Exome Sequencing Insufficient for a Definitive Diagnosis of a Patient with Compound Heterozygous Familial Hypercholesterolemia. [PDF]

Intern Med, 2022
Okada H, Tada H, Nomura A, Nohara A, Okeie K, Nozue T, Michishita I, Takamura M, Takemura H, Kawashiri MA.   +9 more
europepmc   +1 more source

Non-Responder to Inclisiran and Evolocumab-A Female Patient with Heterozygous Familial Hypercholesterolemia and Statin Intolerance. [PDF]

Diseases
Muszyński P, Chlabicz M, Kruszyńska J, Wilk-Śledziewska K, Kazberuk P, Musiałowska D, Groth M, Dudzińska K.   +7 more
europepmc   +1 more source

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels. [PDF]

J Am Heart Assoc, 2022
Funabashi S, Kataoka Y, Hori M, Ogura M, Doi T, Noguchi T, Harada-Shiba M.   +6 more
europepmc   +1 more source

CO18 | Relationship between gut permeability and PCSK9 in heterozygous familial hypercholesterolemia

Bleeding, Thrombosis and Vascular Biology
Background: Gut dysbiosis is a major determinant of low-grade endotoxaemia via dysfunction of the intestinal barrier scaffold, which is a prerequisite for Lipopolysaccharide (LPS) translocation into the systemic circulation.
doaj   +1 more source

Consequences of Late Diagnosis and Insufficient Cholesterol Treatment in Women With Heterozygous Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Santos RD.
europepmc   +1 more source

Risk of fatal stroke in patients with treated familial hypercholesterolemia: A prospective registry study

, 2003
Background and Purpose - Although it is recognized that in heterozygous familial hypercholesterolemia, large extracranial carotid vessels are affected by atherosclerosis, the risk of fatal stroke after treatment with cholesterollowering therapy remains ...
Rachel Huxley (13074081), F Karpe (7715546), HAW Neil (15807215), MH Hawkins (15807605), SE Humphries (7635386)   +4 more
core  

Case Report: Compound heterozygous familial hypercholesterolemia in a pediatric patient with multiple cutaneous xanthomas. [PDF]

Front Pediatr
Yang Q, Jiang L, Wei X, Lv X, Zhao Y, Liu G.   +5 more
europepmc   +1 more source